Daejeon, South Korea

Phil Ho Kim


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Phil Ho Kim: Innovator in Antiviral Pharmaceutical Composition

Introduction

Phil Ho Kim is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiviral agents. His innovative work has the potential to impact the treatment of various viral diseases.

Latest Patents

Phil Ho Kim holds a patent for a compound titled "1,3-Di-oxo-indene derivative, pharmaceutically acceptable salt or optical isomer thereof, preparation method thereof, and pharmaceutical composition containing same as an antiviral, active ingredient." This patent discloses 1,3-Dioxoindene derivatives, which exhibit excellent inhibitory activity against picornaviruses, including coxsackie-, entero-, echo-, polio-, and rhinoviruses. The derivatives also demonstrate low cytotoxicity, making them promising candidates for pharmaceutical compositions aimed at preventing or treating a range of viral diseases.

Career Highlights

Throughout his career, Phil Ho Kim has worked with esteemed institutions such as the Korea Research Institute of Chemical Technology and Katholieke Universiteit Leuven. His research has focused on developing effective antiviral agents that can be utilized in various medical applications.

Collaborations

Phil has collaborated with notable colleagues, including Young Sik Jung and Chong Kgo Lee. Their combined expertise has contributed to the advancement of antiviral research and development.

Conclusion

Phil Ho Kim's innovative work in the field of antiviral pharmaceuticals showcases his dedication to improving healthcare solutions. His contributions have the potential to significantly impact the treatment of viral diseases, highlighting the importance of continued research and development in this area.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…